• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

养老院和护理院中成人呼吸道合胞病毒(RSV)感染负担:一项系统评价。

Burden of Respiratory Syncytial Virus (RSV) Infection Among Adults in Nursing and Care Homes: A Systematic Review.

作者信息

Osei-Yeboah Richard, Amankwah Stephen, Begier Elizabeth, Adedze Miranda, Nyanzu Franklin, Appiah Pious, Ansah Jochebed Ode Boakye, Campbell Harry, Sato Reiko, Jodar Luis, Gessner Bradford D, Nair Harish

机构信息

Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, UK.

Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.

出版信息

Influenza Other Respir Viruses. 2024 Sep;18(9):e70008. doi: 10.1111/irv.70008.

DOI:10.1111/irv.70008
PMID:39284784
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11405123/
Abstract

BACKGROUND

Older adults in nursing and care homes (NCHs) are vulnerable to severe respiratory syncytial virus (RSV) infection, hospitalization, and death. This study aimed to gather data on RSV disease among older adults in NCHs and identify reported risk factors for RSV hospitalization and case fatality.

METHODS

The study protocol was registered in PROSPERO (CRD42022371908). We searched MEDLINE, EMBASE, and Global Health databases to identify articles published between 2000 and 2023. Observational and experimental studies conducted among older adults in NCHs requiring assistive care and reporting RSV illness were included and relevant data were extracted.

RESULTS

Of 18,690 studies screened, 32 were selected for full-text review, and 20 were included. Overall, the number of NCH residents ranged from 42 to 1459 with a mean age between 67.6 and 85 years. Attack rates ranged from 6.7% to 47.6% and annual incidence ranged from 0.5% to 14%. Case fatality rates ranged from 7.7% to 23.1%. We found similar annual incidence rates of RSV-positive acute respiratory infection (ARI) of 4582 (95% CI: 3259-6264) and 4785 (95% CI: 2258-10,141) per 100,000 reported in two studies. Annual incidence rate of RSV-positive lower respiratory tract infection was 3040 (95% CI: 1986-4454) cases per 100,000 adults. Annual RSV-ARI hospital admission rates were between 600 (95% CI: 190-10,000) and 1104 (95% CI: 350-1930) per 100,000 person-years. Among all RSV disease cases, commonly reported chronic medical conditions included chronic obstructive pulmonary disease (COPD), heart failure, ischemic heart disease, coronary artery disease, hypertension, diabetes, kidney dysfunction, cerebrovascular accident, malignancies, dementia, and those with a Charlson comorbidity score > 6.5.

CONCLUSION

Data on RSV infection among NCH residents are limited and largely heterogeneous but document a high risk of illness, frequent hospitalization, and high mortality. Preventive interventions, such as vaccination, should be considered for this high-risk population. Nationally representative epidemiologic studies and NCH-based viral pathogen surveillance could more precisely assess the burden on NCH residents.

摘要

背景

养老院和护理机构中的老年人易感染严重的呼吸道合胞病毒(RSV),并易发生住院和死亡。本研究旨在收集养老院中老年人RSV疾病的数据,并确定报告的RSV住院和病死率的危险因素。

方法

该研究方案已在国际前瞻性系统评价注册库(PROSPERO,注册号:CRD42022371908)登记。我们检索了MEDLINE、EMBASE和全球卫生数据库,以确定2000年至2023年期间发表的文章。纳入了在需要辅助护理的养老院老年人中进行的观察性和实验性研究,这些研究报告了RSV疾病,并提取了相关数据。

结果

在筛选的18690项研究中,32项被选进行全文审查,20项被纳入。总体而言,养老院居民人数从42人到1459人不等,平均年龄在67.6岁至85岁之间。发病率从6.7%到47.6%不等,年发病率从0.5%到14%不等。病死率从7.7%到23.1%不等。我们在两项研究中发现,每10万人中RSV阳性急性呼吸道感染(ARI)的年发病率相似,分别为4582例(95%置信区间:3259 - 6264)和4785例(95%置信区间:2258 - 10141)。RSV阳性下呼吸道感染的年发病率为每10万成年人3040例(95%置信区间:1986 - 4454)。RSV-ARI的年住院率在每10万人年600例(95%置信区间:190 - 10000)至1104例(95%置信区间:350 - 1930)之间。在所有RSV疾病病例中,常见的慢性疾病包括慢性阻塞性肺疾病(COPD)、心力衰竭、缺血性心脏病、冠状动脉疾病、高血压、糖尿病、肾功能不全、脑血管意外、恶性肿瘤、痴呆以及Charlson合并症评分>6.5的患者。

结论

养老院居民中RSV感染的数据有限且差异很大,但记录了疾病风险高、频繁住院和高死亡率的情况。对于这一高危人群,应考虑采取预防干预措施,如接种疫苗。全国代表性的流行病学研究和基于养老院的病毒病原体监测可以更准确地评估养老院居民的负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5633/11405123/c39a008f90d9/IRV-18-e70008-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5633/11405123/c39a008f90d9/IRV-18-e70008-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5633/11405123/c39a008f90d9/IRV-18-e70008-g001.jpg

相似文献

1
Burden of Respiratory Syncytial Virus (RSV) Infection Among Adults in Nursing and Care Homes: A Systematic Review.养老院和护理院中成人呼吸道合胞病毒(RSV)感染负担:一项系统评价。
Influenza Other Respir Viruses. 2024 Sep;18(9):e70008. doi: 10.1111/irv.70008.
2
Global Disease Burden Estimates of Respiratory Syncytial Virus-Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis.2015 年全球老年人呼吸道合胞病毒相关急性呼吸道感染疾病负担估计:系统评价和荟萃分析。
J Infect Dis. 2020 Oct 7;222(Suppl 7):S577-S583. doi: 10.1093/infdis/jiz059.
3
Burden of Respiratory Syncytial Virus Disease in Adults with Asthma and Chronic Obstructive Pulmonary Disease: A Systematic Literature Review.哮喘和慢性阻塞性肺疾病成人患者呼吸道合胞病毒病负担:一项系统文献综述
Curr Allergy Asthma Rep. 2025 Feb 25;25(1):14. doi: 10.1007/s11882-025-01194-w.
4
Burden of Respiratory Syncytial Virus-Associated Hospitalizations in US Adults, October 2016 to September 2023.美国成年人呼吸道合胞病毒相关住院负担,2016 年 10 月至 2023 年 9 月。
JAMA Netw Open. 2024 Nov 4;7(11):e2444756. doi: 10.1001/jamanetworkopen.2024.44756.
5
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.2019 年全球、区域和国家因呼吸道合胞病毒导致 5 岁以下儿童急性下呼吸道感染的疾病负担估计:系统分析。
Lancet. 2022 May 28;399(10340):2047-2064. doi: 10.1016/S0140-6736(22)00478-0. Epub 2022 May 19.
6
Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data.2019 年导致早产儿和幼儿急性下呼吸道感染的呼吸道合胞病毒的全球疾病负担及危险因素:汇总和个体参与者数据的系统评价和荟萃分析。
Lancet. 2024 Mar 30;403(10433):1241-1253. doi: 10.1016/S0140-6736(24)00138-7. Epub 2024 Feb 14.
7
Burden of respiratory syncytial virus (RSV) infection in Germany: a systematic review.德国呼吸道合胞病毒(RSV)感染负担:系统评价。
BMC Infect Dis. 2024 Aug 20;24(1):844. doi: 10.1186/s12879-024-09758-3.
8
Disease Burden Estimates of Respiratory Syncytial Virus related Acute Respiratory Infections in Adults With Comorbidity: A Systematic Review and Meta-Analysis.疾病负担估计:合并症成人呼吸道合胞病毒相关急性呼吸道感染:系统评价和荟萃分析。
J Infect Dis. 2022 Aug 12;226(Suppl 1):S17-S21. doi: 10.1093/infdis/jiab040.
9
Respiratory syncytial virus infection in Guatemala, 2007-2012.2007-2012 年危地马拉呼吸道合胞病毒感染。
J Infect Dis. 2013 Dec 15;208 Suppl 3:S197-206. doi: 10.1093/infdis/jit517.
10
Burden of respiratory syncytial virus infections in older adults with acute respiratory infection in Japan: An epidemiological study among outpatients.日本急性呼吸道感染老年患者呼吸道合胞病毒感染负担:一项门诊患者的流行病学研究。
Respir Investig. 2024 Sep;62(5):914-921. doi: 10.1016/j.resinv.2024.06.003. Epub 2024 Aug 9.

引用本文的文献

1
Adult Vaccinations Today-Innovations and Challenges for the Coming Years.当今成人疫苗接种——未来几年的创新与挑战
Vaccines (Basel). 2025 May 29;13(6):583. doi: 10.3390/vaccines13060583.
2
Respiratory syncytial virus (RSV) infections in adults: Current trends and recommendations for prevention - a global challenge from a local perspective.成人呼吸道合胞病毒(RSV)感染:当前趋势及预防建议——从地方视角看全球挑战
Hum Vaccin Immunother. 2025 Dec;21(1):2514357. doi: 10.1080/21645515.2025.2514357. Epub 2025 Jun 18.
3
Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options.

本文引用的文献

1
Systematic Literature Review of Risk Factors for Poor Outcomes Among Adults With Respiratory Syncytial Virus Infection in High-Income Countries.高收入国家成人呼吸道合胞病毒感染不良结局危险因素的系统文献综述
Open Forum Infect Dis. 2023 Oct 20;10(11):ofad513. doi: 10.1093/ofid/ofad513. eCollection 2023 Nov.
2
Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.《老年人使用呼吸道合胞病毒疫苗:免疫实践咨询委员会的建议——美国,2023 年》。
MMWR Morb Mortal Wkly Rep. 2023 Jul 21;72(29):793-801. doi: 10.15585/mmwr.mm7229a4.
3
呼吸道合胞病毒:关于新预防方案的瓦迪德共识文件
Vaccines (Basel). 2024 Nov 25;12(12):1317. doi: 10.3390/vaccines12121317.
Incidence of Respiratory Syncytial Virus Infection in Older Adults: Limitations of Current Data.
老年人呼吸道合胞病毒感染的发病率:当前数据的局限性
Infect Dis Ther. 2023 Jun;12(6):1487-1504. doi: 10.1007/s40121-023-00802-4. Epub 2023 May 23.
4
RSV vaccines score landmark FDA approvals.呼吸道合胞病毒疫苗获得美国食品药品监督管理局的重大批准。
Nat Rev Drug Discov. 2023 Jul;22(7):523-525. doi: 10.1038/d41573-023-00085-x.
5
Estimation of the Number of Respiratory Syncytial Virus-Associated Hospitalizations in Adults in the European Union.估计欧盟成年人中与呼吸道合胞病毒相关的住院人数。
J Infect Dis. 2023 Nov 28;228(11):1539-1548. doi: 10.1093/infdis/jiad189.
6
Diagnosis of Respiratory Syncytial Virus in Adults Substantially Increases When Adding Sputum, Saliva, and Serology Testing to Nasopharyngeal Swab RT-PCR.在成人呼吸道合胞病毒诊断中,将痰液、唾液和血清学检测添加到鼻咽拭子逆转录聚合酶链反应(RT-PCR)检测中时,诊断率大幅提高。
Infect Dis Ther. 2023 Jun;12(6):1593-1603. doi: 10.1007/s40121-023-00805-1. Epub 2023 May 6.
7
First RSV vaccine for older adults is approved in Europe.欧洲批准了首款用于老年人的呼吸道合胞病毒疫苗。
BMJ. 2023 Apr 28;381:978. doi: 10.1136/bmj.p978.
8
Respiratory Syncytial Virus Disease Burden in Community-Dwelling and Long-Term Care Facility Older Adults in Europe and the United States: A Prospective Study.欧美社区居住及长期护理机构老年人呼吸道合胞病毒疾病负担:一项前瞻性研究
Open Forum Infect Dis. 2023 Mar 1;10(4):ofad111. doi: 10.1093/ofid/ofad111. eCollection 2023 Apr.
9
Adjusting for Case Under-Ascertainment in Estimating RSV Hospitalisation Burden of Older Adults in High-Income Countries: a Systematic Review and Modelling Study.在估算高收入国家老年人呼吸道合胞病毒住院负担时对病例未充分确诊情况进行调整:一项系统评价与建模研究
Infect Dis Ther. 2023 Apr;12(4):1137-1149. doi: 10.1007/s40121-023-00792-3. Epub 2023 Mar 20.
10
Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States.美国因下呼吸道感染住院的成年人中呼吸道合胞病毒检测水平较低。
Infect Dis Ther. 2023 Feb;12(2):677-685. doi: 10.1007/s40121-023-00758-5. Epub 2023 Jan 27.